In the current era, complete revascularization improves survival after coronary artery bypass surgery  by Kleisli, Thomas et al.
Kleisli et al Surgery for Acquired Cardiovascular DiseaseIn the current era, complete revascularization improves
survival after coronary artery bypass surgery
Thomas Kleisli, BS, Wen Cheng, MD, Milagros J. Jacobs, MPH, James Mirocha, MS, Michele A. DeRobertis, RN,
Robert M. Kass, MD, Carlos Blanche, MD, Gregory P. Fontana, MD, Sharo S. Raissi, MD, Kathy E. Magliato, MD, and
Alfredo Trento, MD
A
CDFrom the Division of Cardiothoracic Sur-
gery, Cedars-Sinai Medical Center, Los
Angeles, Calif.
Read at the Thirtieth Annual Meeting of
The Western Thoracic Surgical Associa-
tion, Maui, Hawaii, June 23-26, 2004.
Received for publication June 21, 2004;
revisions received Dec 14, 2004; accepted
for publication Dec 20, 2004.
Address for reprints: Wen Cheng, MD, Di-
vision of Cardiothoracic Surgery, Cedars-
Sinai Medical Center, 8700 Beverly Blvd,
North Tower, Suite 6215, Los Angeles, CA
90048 (E-mail: chengw@cshs.org).
J Thorac Cardiovasc Surg 2005;129:1283-91
0022-5223/$30.00
Copyright © 2005 by The American Asso-
ciation for Thoracic Surgery
De Robertis, Kleisli, Jacobs, Cheng (left to right)
An appendix containing tables
and illustrations is available
online.doi:10.1016/j.jtcvs.2004.12.034
TBackground: Complete revascularization has been the standard for coronary bypass
grafting. However, surgical intervention has evolved with increasing use of arterial
conduits and off-pump techniques.
Methods: Patients undergoing non-redo bypass surgery from January 1998 through
December 2000 were followed up with questionnaires and telephone contact.
Incomplete revascularization was defined as absence of bypass grafts placed to a
coronary territory supplied by a vessel with 50% or greater stenosis.
Results: One thousand thirty-four patients were followed for a mean of 3.3  1.6
years. Complete revascularization was found in 937 (90.6%) patients, and incom-
plete revascularization was found in 97 (9.4%) patients. Eight hundred twenty-seven
(80.4%) patients underwent on-pump operations, and 207 (19.6%) underwent off-
pump operations. Incomplete revascularization was more prevalent in off-pump
versus on-pump operations (21.7% vs 6.3%, P  .001). Multivariable Cox regres-
sion analysis indicated that in-hospital cerebrovascular accidents (hazard ratio, 5.49;
P  .001), chronic obstructive pulmonary disease (hazard ratio, 1.97; P  .019),
and incomplete revascularization (hazard ratio, 1.85; P  .040) predicted an
increased hazard (risk) of cardiac death. Left internal thoracic artery (hazard ratio,
0.38; P  .047), right internal thoracic artery (hazard ratio, 0.25; P  .019), and
radial artery (hazard ratio, 0.36; P .001) grafting reduced the risk of cardiac death.
The 5-year unadjusted survival rate was 52.6% versus 82.4% in patients undergoing
incomplete and complete revascularization (P .001), with cardiac survival rates of
74.5% versus 93.1%, respectively (P  .001). However, this difference in cardiac
survival was smaller in octogenarians with incomplete versus complete revascular-
izations (77.4% vs 87.6%, P  .101) and was essentially absent in off-pump versus
on-pump operations if complete revascularization was achieved in both cases
(93.6% vs 93.1%, P  .200).
Conclusions: Complete revascularization and arterial grafting improve 5-year sur-
vival. Off-pump techniques do not affect survival. Complete revascularization
should be performed whenever possible.
Complete myocardial revascularization is superior to incomplete revascular-ization, with greater long-term survival and freedom from reintervention incoronary artery bypass grafting (CABG). However, studies validating this
were done in an earlier era with mainly saphenous vein grafting (SVG) and younger
patient populations.1,2 Contemporary surgical studies question the benefits of com-
plete revascularization (CRV) on long-term survival.3,4 Myocardial revasculariza-
tion techniques have evolved in the last decade. Internal thoracic artery (ITA)
bypass grafting is now the gold standard, and free radial arteries are increasingly
used instead of saphenous veins. Off-pump cardiac surgical techniques have been
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CDadopted, with a consequence of more incomplete revascu
larization (IRV). 5,6 The mean age of surgical patients is
approaching 70 years, with an increasing number of 80-
year-old patients undergoing CABG.5 Are-evaluation of the
importance of completeness of revascularization on out-
comes after CABGis warranted.
Patients and Methods
All patients undergoing isolated non-redo CABGthrough a me-
dian sternotomy at Cedars-Sinai Medical Center between January
1, 1998,and December 31,2000,were analyzed. The preoperative
coronary angiogram reports and the preoperative surgical consul
tations were used to determine the location of significant coronary
artery obstructions in each patient. Type of conduit used and
coronary vessels grafted were obtained from the surgical operativ
reports. All patients’ data were entered into our cardiac surgical
database, which follows576preoperative, intraoperative, and post-
operative variables. Follow-up was conducted by using annual
questionnaires and telephone contact to confirm outcomes. A tota
of 1034patients were available for analysis.
Completeness of Revascularization
The definition of CRVis controversial. The traditional approach
assumes one graft for every significantly obstructed coronary
artery, whereas functional revascularization uses one graft for all
diseased primary arterial territories. The left anterior descending
artery (LAD),the circumflex artery, and the right coronary artery
(RCA) define the coronary territories. Vander Salm and col-
leagues4 compared these 2 definitions in the Bypass Angioplasty
Revascularization Investigation (BARI)study and found no sig-
nificant survival advantage for either compared with patients with
IRV.Most surgical groups have adopted the functional definition
in their studies.1-3,6 We used both a traditional and functional
definition and found 101 patients versus 97 patients, respectively,
with IRV.Of the 4 additional patients in the traditional group, 3
patients had 1 ungrafted circumflex marginal branch, and 1 patient
had an ungrafted intermediate circumflex branch. This difference
of 4 patients did not prove significant in any of the subsequent
analyses. We therefore elected to use a functional definition to
mirror other previous studies of completeness of revascularization.
The coronary vascular tree was divided into 3 separate territo
ries: the LAD,the circumflex artery, and the RCA.One-territory
disease was classified as an isolated 50% or greater diamete
narrowing in at least 1 blood vessel supplying a single vascular
territory. Two-territory disease involved 50% or greater vessel
narrowing to 2 separate territories or isolated left main (LM)
narrowing of 50% or greater not involving the RCA territory.
Three-territory disease included 50% or greater vessel narrowing
to all 3 territories or isolated LMnarrowing and RCAnarrowing
together.
CRVwas achieved when at least one bypass graft was placed
distal to a 50%or greater narrowing in each diseased territory. LM
territory disease would require bypass grafting to both the LAD
and the circumflex territory to be considered complete. Nongraft-
ing of any significantlynarrowed vascular territory was considered
IRV.
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The primary outcomes were all-cause and cardiac mortalityoccur-
ring from the time of the operation through the last day of follow-
up, May 1, 2004.The primary cause of death was categorized by
the operating surgeon or the principal surgical investigator for the
study (W.C.). Specific classifications for cause of death were
cardiac and noncardiac. Cardiac causes of death included dire
causes, such as sudden cardiac death, heart failure (pump), an
arrhythmia (documented ventricular tachycardia or fibrillation).
Secondary outcomes were reinterventions, including angioplasty
stenting, and reoperative CABG.In addition, we performed sub-
group analyses of primary end points in patients 80 or more and
less than 80 years of age.
Statistical Analysis
Results for continuous variables were expressed as mean stan-
dard deviation. Results for categorical variables were expressed as
number (percentage). Two-group differences for continuous and qua-
sicontinuous variables were assessed by the independent-samples t
test, with adjusted degrees of freedom (Satterthwaite) when there
was evidence against the homogeneity of variance assumption.
Group differences for categorical variables were assessed by the 2
and Fisher exact tests. Predictors of IRV were assessed by stepwise
multivariable logistic regression. Odds ratios (ORs) with 95%
confidence intervals were given for the predictor variables in the
final logistic regression model. Nonparametric estimates of sur-
vival from all-cause and cardiac death were estimated for each
comparison group by the Kaplan-Meier method. Group differences
in survival functions were assessed by the log-rank test. Variables
related to the hazards for all-cause and cardiac death were assessed
by stepwise Cox proportional hazards models. The proportional
hazards assumption was checked by assessing the interaction of
time with each significant predictor in the Cox model and also by
investigating the Schoenfeld residuals for each significant predic-
tor. Hazard ratios (HRs) with 95% confidence intervals were given
for the predictor variables in the final Cox models. A list of the
candidate predictors for the stepwise analyses is contained in Table
E1 (available online). Calculations were performed with SAS
version 8.2 (SAS Institute, Cary, NC).
Off-Pump Coronary Artery Bypass Learning Curve
All operations involved 2 attending surgeons, serving as surgeon
and first assistant surgeon, who performed the proximal and distal
anastomoses. The 6 attending surgeons, who were present during
the entire period of the study, participated in a minimum of 95 to
a maximum of 149 cases through December 31, 2000. There was
a gradual adoption of off-pump techniques, with 3.5% of off-pump
coronary artery bypass (OPCAB) procedures performed in 1996,
9% in 1997, 15.2% in 1998, 28.1% in 1999, and 26.4% in 2000.
OPCAB Patient Selection
The choice of OPCAB versus on-pump CABG was the surgeon’s
preference. Factors favoring OPCAB included patients with suit-
able anatomy, epicardial target vessels of 1 mm or larger that were
noncalcified and easy to expose, patients considered at high risk
for cardiopulmonary bypass (CPB), elderly patients with multiple
preoperative morbidities, and especially patients with significant
calcification of the ascending aorta and vascular disease.
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small, calcified, intramyocardial coronary targets. Difficulty in
vessel exposure and unstable condition of the patient also pre-
cluded an off-pump approach. All 1034 operations were performed
at Cedars-Sinai Medical Center.
Surgical Technique
OPCAB. A median sternotomy was used. Proximal and distal
coronary artery flow was controlled with silicone rubber loops
(Retract-O-Tape; Quest, Allen, Tex). Blood was cleared from the
anastomotic site with a commercial carbon dioxide saline blower
(Clearview blower/mister kit; Medtronic, Inc, Minneapolis, Minn).
Commercial stabilizers included suction stabilizers (Medtronic
Octopus I and II; Medtronic, Inc) and U-shaped foot stabilizers
(Universal Stabilizers System; Estech Systems, Inc, Danville,
Calif). A heparin dose of 10,000 units was given before vessel
occlusion, and the activated clotting time was maintained at twice
control activated clotting time. Heparin was fully reversed before
sternal closure.
We selectively used coronary shunts (Flo-Thru intraluminal
shunt; Bio-Vascular, Inc, St Paul, Minn), primarily in constructing
bypass grafts to dominant RCAs. Exposure for lateral and inferior
wall vessels was originally achieved by using a combination of
deep pericardial stitches, an opening of the right side of the
pericardium to the inferior vena cava–right atrial junction, and a
right decubitus Tendelenburg position. Subsequently, apical suc-
tion stabilizers were used. Proximal anastomoses were made to the
ascending aorta with the systolic blood pressure between 70 and 80
mm Hg and a curved vascular clamp. If significant aortic calcifi-
cation precluded safe clamp placement, proximal anastomoses
were made to the side of the ITA.
Conventional CABG. CABG was performed through a me-
dian sternotomy during moderate hypothermia (32°C) and CPB
support. Single-dose, antegrade, cold blood cardioplegia was sup-
plemented with cold, continuous, retrograde crystalloid cardiople-
gia and topical iced slush to protect the myocardium. Proximal
anastomoses were performed during a single period of aortic
crossclamping. The CPB circuit consists of a roller pump (Jostra
Bentley Corp, Irvine, Calif) and membrane oxygenator (Avecor
Affinity; Medtronic, Inc). Patients undergoing both OPCAB and
on-pump CABG were discharged receiving either aspirin or war-
farin sodium (Coumadin; DuPont Merck, Wilmington, Del) if their
heart rhythm was classified as atrial fibrillation.
Results
Characteristics of subjects according to completeness of
revascularization and use of CPB are shown in Tables 1 and 2.
Follow-up was available for 1034 patients, with a mean of
3.3  1.6 years. There were 97 (9.4%) patients with IRV
and 937 (90.6%) patients with CRV. The mean age of the
patients with IRV (71.7  12.1 years) was significantly
greater than that of the patients with CRV (67.4  10.8
years, P  .001), with a greater proportion of octogenarians
(24.7% vs 11.2%, P  .001). The mean number of diseased
territories was greater in the patients with IRV (2.9 0.3 vs
2.6  0.6, P  .001; Table 1); however, the number of
grafts placed was nearly 1 less per patient (2.3  0.8 vs 3.2
The Journal of Thoracic 0.9, P  .001; Table 2). More than one fifth (21.7%) of
the patients undergoing OPCAB had IRV, which was sig-
nificantly higher than in the on-pump CABG group (6.3%,
P  .001). Patients undergoing OPCAB tended to be older
(70.8  12.3 vs 67.0  10.6 years, P  .001), with more
octogenarians (24.2% vs 9.6%, P  .001). Patients under-
going OPCAB also had fewer diseased territories (2.2 0.8
vs 2.8  0.4, P  .001) and nearly 1½ fewer bypass grafts
(2.0  0.7 vs 3.4  0.8, P  .001; Tables 1 and 2).
Reasons for IRV
The most common reason recorded for IRV was that the
arteries were too small, severely diseased, or both (Table
E2). Nondominant RCA and the presence of prior infarcted
tissue were the next most frequently recorded reasons. High
surgical risk was cited only in 12 of the patients undergoing
OPCAB. Significant collateral formation and lack of con-
duit availability were the next most frequent. Lack of a
discernible reason was present only in 7 patients.
Multivariable Regression Analysis
Fifteen predictor variables were entered into a stepwise
logistic regression analysis examining the determinants of
IRV (see Table E1 [Appendix] for the list of predictor
variables). The variables found to be significant in the final
model included off-pump surgery (OR, 12.75; P  .001),
number of diseased coronary territories (OR, 11.61; P 
.001), female sex (OR, 2.09; P  .002), prior myocardial
infarction (OR, 1.72; P  .030), and ejection fraction (OR,
0.98; P  .003; Table 3).
There were 163 all-cause deaths, of which 68 were
cardiac deaths. Nineteen variables were entered into the Cox
proportional hazards regression analysis (see Table E1 [Ap-
pendix]). The variables found to be significant included
in-hospital cerebrovascular accident (CVA; HR, 4.23; P 
.001), chronic obstructive pulmonary disease (HR, 2.12;
P  .001), congestive heart failure (HR, 1.89; P  .001),
IRV (HR, 1.73; P  .006), and age (HR, 1.03; P  .001;
Table 4). Use of right internal thoracic artery (RITA) grafts
(HR, 0.51; P  .050) and radial artery grafts (HR, 0.49; P
 .001) were associated with a lower risk of all-cause death.
Similar proportional hazards results were found for car-
diac death, with in-hospital CVA (HR, 5.49; P  .001),
chronic obstructive pulmonary disease (HR, 1.97; P 
.019), and IRV (HR, 1.85; P  .040) increasing the risk of
cardiac death (Table 4). Age was no longer significantly
important for cardiac death. A decreased risk of cardiac
death was associated with an increase in ejection fraction
(HR, 0.96; P  .001) and arterial grafting, including left
internal thoracic artery (LITA; HR, 0.38; P  .047), RITA
(HR, 0.25; P .019) and radial artery (HR, 0.36; P .001)
grafting.
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The Kaplan-Meier 5-year cumulative survival curves for
subjects according to completeness of revascularization and
CPB status are presented in Figures 1, 2, E1, and E2.
Patients with IRV did significantly worse at 5 years than
patients with CRV. However, patients undergoing off-pump
CABG had similar survival as those undergoing on-pump
CABG when both had CRV (93.6% vs 93.1%, P  .200;
Figure 2, B).
Discussion
Complete myocardial revascularization is a long-held tenet
of surgical coronary artery revascularization. Both a report
from the Coronary Artery Surgery Registry in 1992 and
from Emory University in 1996 established the long-term
survival benefit of CRV in cardiac surgical patients.1,2 The
Coronary Artery Surgery study followed 3372 patients un-
dergoing isolated CABG between July 1974 and June 1979,
among whom the mean age of patients was 56 years and in
whom the saphenous vein was generally used, with 16% of
patients receiving an ITA graft alone or in combination with
TABLE 1. Baseline characteristics according to completen
Characteristic
Complete
revascularization
(n  937)
Inco
revascu
(n 
Demographics
Age (y) 67.4 10.8 71.7
Age 80 y 105 (11.2) 24 (
Risk factors
Female 232 (24.8) 36 (
DM 291 (31.1) 44 (
HTN 615 (65.6) 65 (
COPD 105 (11.2) 19 (
PVD 170 (18.1) 32 (
Acute MI 151 (16.1) 28 (
Urgent/emergency status 307 (33.0) 42 (
LVEF 50% 259 (27.7) 42 (
CHF (NYHA class III-IV) 115 (12.3) 26 (
Diseased territories
LM 232 (24.8) 32 (
LAD 868 (92.6) 93 (
Cx 703 (75.0) 87 (
RCA 761 (81.2) 94 (
No. of diseased territories
One territory 55 (5.9) 0 (
Two territories 242 (25.8) 8 (
Three territories 640 (68.3) 89 (
No. of territories diseased 2.6 0.6 2.9
Variables are expressed as mean  standard deviation or number (perce
hypertension; COPD, chronic obstructive pulmonary disease; PVD, periphe
ventricular ejection fraction; LM, left main; LAD, left anterior descending;saphenous veins. The 2860 Emory group patients enrolled
1286 The Journal of Thoracic and Cardiovascular Surgery ● Junbetween January 1978 and December 1981 were similar,
with a mean age of 57 years and infrequent reported use of
ITA grafting. These benchmark studies’ major shortcoming
is the infrequent use of arterial grafting in this earlier
generation of younger patients.
More current studies, which use a greater percentage of
arterial grafting, have called into question the benefit of CRV.
Moon and associates3 reported that in octogenarian patients
with increased ITA use (65%), CRV did not improve survival.
In the BARI study from August 1988 through August 1991,
1526 patients underwent CABG. The average age was 62
years, with more than 80% of the patients receiving ITA
grafting. The BARI investigators were unable to demonstrate a
survival advantage compared with IRV to 7 years of follow-
up.4 Improvements in myocardial protection and more frequent
ITA grafting might have decreased the survival benefit of CRV
seen in an earlier era of primarily saphenous vein grafting. In
addition, older patients might not live long enough to realize
the benefits of CRV.
We observed 1034 patients undergoing isolated non-redo
CABG at a single institution from January 1998 through
of revascularization and use of cardiopulmonary bypass
e
tion
P value
On-pump
(n  827)
OPCAB
(n  207) P value
.1 .001 67.0 10.6 70.8 12.3 .001
.001 79 (9.6) 50 (24.2) .001
.010 216 (26.1) 52 (25.1) .200
.006 283 (34.2) 52 (25.1) .013
.200 551 (66.6) 129 (62.3) .200
.021 97 (11.7) 27 (13.0) .200
.001 154 (18.6) 48 (23.2) .142
.003 147 (17.8) 32 (15.5) .200
.074 283 (34.4) 66 (32.0) .200
.002 254 (30.8) 47 (22.7) .026
.001 107 (12.9) 34 (16.4) .200
.087 214 (25.9) 50 (24.2) .200
.200 768 (92.9) 193 (93.2) .200
.001 690 (83.4) 100 (48.3) .001
.001 727 (87.9) 128 (61.8) .001
.007 8 (1.0) 47 (22.7) .001
.001 171 (20.7) 79 (38.2) .001
.001 648 (78.4) 81 (39.1) .001
.001 2.8 0.4 2.2  0.8 .001
). OPCAB, Off-pump coronary artery bypass; DM, diabetes mellitus; HTN,
scular disease; acute MI, myocardial infarction this admission; LVEF, left
ircumflex; RCA, right coronary artery.ess
mplet
lariza
97)
 12
24.7)
37.1)
45.4)
67.0)
19.6)
33.0)
28.9)
42.4)
43.3)
26.8)
33.0)
95.9)
89.7)
96.9)
0.0)
8.3)
91.8)
 0.3
ntage
ral vaDecember 2000. During this time span, there were few
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CDchanges in our surgical technique. OPCAB was well estab-
lished at this time, with all of the surgeons familiar with its
use. Radial artery and bilateral ITA grafting were frequently
used techniques.
We found that patients with IRV had a decreased long-
term survival out to 5 years when compared with patients
with CRV. However, the survival benefit of CRV was less
in octogenarians. The 5-year survival was better but did not
reach clinical significance. The major benefit of CRV was
seen in patients less than 80 years of age. This makes sense
because these patients have a longer expected survival, and
there were more patients available to statistically confirm
any difference in outcome.
One of the most striking features in the follow-up is the
magnitude of the survival difference between patients with
CRV and patients with IRV out to 5 years. The survival curves
progressively diverge throughout the 5-year period. IRV cer-
tainly accounts for a significant proportion of this. However,
the type of grafting might also play a significant role. Nearly
everyone received a LITA graft. In addition, patients with
CRV received significantly more arterial grafting with RITAs
TABLE 2. Procedural characteristics and outcomes in rela
pulmonary bypass
Characteristic
Complete
revascularization
(n  937)
Incom
revascu
(n 
Procedural characteristics
CABG, on-pump 775 (82.7) 52 (
CABG, OPCAB 162 (17.3) 45 (
CABG, as CRV –
CABG, as IRV –
No. of grafts placed 3.2 0.9 2.3
Territories grafted
LAD 922 (98.4) 94 (
Cx 778 (83.0) 50 (
RCA 761 (81.2) 32 (
Conduits used
LITA 914 (97.6) 94 (
RITA 203 (21.7) 10 (
Radial artery 550 (58.7) 37 (
Saphenous vein 707 (75.5) 58 (
Complications
MI 10 (1.1) 0 (
CVA 19 (2.0) 7 (
Mortality 25 (2.7) 5 (
Reinterventions
PTCA 19 (2.0) 0 (
Surgical intervention 2 (0.2) 1 (
Variables are expressed as mean  standard deviation or number (percen
grafting; CRV, complete revascularization; IRV, incomplete revascularization
artery; LITA, left internal thoracic artery; RITA, right internal thoracic artery
mortality or 30-day mortality; PTCA, percutaneous transluminal coronary aand radial arteries. In the Cox proportional hazards analysis,
The Journal of ThoracicIRV increased the chance of cardiac and all-cause death be-
tween 70% and 80%. Receiving a radial artery graft, RITA
graft, or both decreased the chance of all-cause death about
50% and cardiac death between 60% and 80%.
We also found more IRV in patients undergoing
OPCAB.5,6 Although some experienced OPCAB surgeons
have demonstrated the ability to achieve 100% CRV in
these patients,7 most series confirm a near doubling of IRV
to completeness of revascularization and use of cardio-
tion
P value
On-pump
(n  827)
OPCAB
(n  207) P value
.001 – – –
.001 – – –
– 775 (93.7) 162 (78.3) .001
– 52 (6.3) 45 (21.7) .001
.001 3.4 0.8 2.0 0.7 .001
.200 816 (98.7) 200 (96.6) .067
.001 752 (90.9) 76 (36.7) .001
.001 706 (85.4) 87 (42.0) .001
.200 806 (97.5) 202 (97.6) .200
.008 187 (22.6) 26 (12.6) .001
.001 509 (61.6) 78 (37.7) .001
.001 681 (82.4) 84 (40.6) .001
.200 10 (1.2) 0 (0.0) .200
.008 21 (2.5) 5 (2.4) .200
.192 24 (2.9) 6 (2.9) .200
.200 16 (1.9) 3 (1.5) .200
.200 2 (0.2) 1 (1.0) .200
. OPCAB, Off-pump coronary artery bypass; CABG, coronary artery bypass
, left anterior descending artery; Cx, circumflex artery; RCA, right coronary
yocardial infarction; CVA, cerebrovascular accident;Mortality, in-hospital
lasty.
TABLE 3. Predictors of incomplete revascularization:
Results of multivariable logistic regression
Incremental risk factors
Multivariable
OR 95% CI P value
Off-pump 12.75 7.49-22.72 .001
No. of territories diseased 11.61 5.33-25.27 .001
Female sex 2.09 1.37-3.66 .002
Prior MI 1.72 1.05-2.82 .030
EF 0.98 0.97-0.99 .003
OR, Odds ratio; CI, confidence interval; MI, myocardial infarction; EF,tion
plete
lariza
97)
53.6)
46.4)
–
–
0.8
96.9)
51.6)
33.0)
96.9)
10.3)
38.1)
59.8)
0.0)
7.2)
5.2)
0.0)
1.0)
tage)
; LAD
;MI, mejection fraction.
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seen in OPCAB were due to this higher prevalence of IRV.
We did not observe an increase in cardiac mortality for
patients undergoing OPCAB if they received CRV.
We examined the reasons for IRV in our patients to see
whether there was a rationale for the higher incidence of
IRV seen in our patients undergoing OPCAB. The patients
undergoing on-pump bypass who were incompletely revas-
Figure 1. A, Cumulative unadjusted survival from all-
unadjusted survival from cardiac death in patients w
TABLE 4. Predictors of death: Cox proportional hazards m
Incremental risk factors
All-cause death
HR 95% CI
CVA, in-hospital 4.23 2.46-7.27
COPD 2.12 1.47-3.06
CHF 1.89 1.33-2.69
IRV 1.73 1.18-2.55
Age 1.03 1.02-1.05
EF 0.98 0.97-0.99
LITA – –
RITA 0.51 0.26-1.00
Radial artery 0.49 0.34-0.70
HR, Hazard ratio; CI, confidence interval; CVA, cerebrovascular accident; C
incomplete revascularization; EF, ejection fraction; LITA, left internal thorarepresent 5-year survival percentages.
1288 The Journal of Thoracic and Cardiovascular Surgery ● Juncularized typically gave reasons that minimized the impor-
tance of nongrafting, such as small and/or severe disease,
nondominant RCA, prior infarcted myocardium, or the pres-
ence of collateral vessels. This represented 85% of stated
reasons for IRV in the on-pump group. The remaining 15%
were lack of conduit availability and “no reason given.” The
patients undergoing OPCAB with IRV had only 55% of
reasons that minimized nongrafting. However, about a quar-
e death in patients with CRV and IRV. B, Cumulative
RV and CRV. Numbers in parentheses (percentages)
Cardiac death
P value HR 95% CI P value
.001 5.49 2.41-12.51 .001
.001 1.97 1.12-3.48 .019
.001 – – –
.006 1.85 1.03-3.34 .040
.001 – – –
.001 0.96 0.95-0.98 .001
– 0.38 0.15-0.99 .047
.050 0.25 0.08-0.80 .019
.001 0.36 0.21-0.64 .001
chronic obstructive pulmonary disease; CHF, congestive heart failure; IRV,
rtery; RITA, right internal thoracic artery.caus
ith Iodel
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CDter (12 patients) were considered high risk, and a preoperative
decision was made to do a simpler operation of OPCAB to
anterior wall targets, leaving the lateral wall, inferior wall,
or both ungrafted. However, this difference in stated reasons
for IRV between the on-pump and OPCAB groups did not
result in a difference in cardiac survival (Figure 2, B). It
seems that at least a percentage of patients undergoing
OPCAB had IRV planned preoperatively. When having
undertaken OPCAB operations, our cardiac surgeons were
more likely to leave territories incompletely revascularized,
although not always indicating specific reasons. The reason
for choosing OPCAB was surgeon preference and was
frequently not explained in the medical record.
IRV had a significant negative effect on patient sur-
vival and should be avoided when possible. Whether this
is achieved with an on-pump or off-pump technique is
unimportant. In addition, arterial grafting with the LITA,
the RITA, and the radial artery independently improve
survival. We currently attempt to maximize the benefits
Figure 2. A, Cumulative unadjusted survival from all
off-pump (Off) CABG and patients with CRV and IRV.
patients undergoing on-pump (On) and off-pump (Off)
theses (percentages) represent 5-year survival percenof arterial grafting by using more sequential LITA grafts,
The Journal of Thoracicas well as RITA grafts, for both left- and right-sided
targets. The radial artery of the nondominant extremity, if
the result of the Allen test is normal, has become our
preferred conduit versus the saphenous vein. Bilateral
radial artery use has become increasingly used. By using
these multiple arterial conduits, it is presently rare that
we are unable to completely revascularize our patients.
We continue to use OPCAB for patients we consider at
high risk for CPB, such as patients with calcified aortas
and older patients with prior CVAs and anyone with
significant carotid disease. However, we currently place
greater emphasis on completely revascularizing all pa-
tients undergoing OPCAB with the aid of apical suction
stabilizer’s for better access to the inferior and lateral
walls of the heart. In the unstable high-risk patient in
whom grafting of the lateral wall is difficult or impossi-
ble, we have achieved CRV with a hybrid procedure
consisting of off-pump grafting of accessible anterior
wall targets and balloon angioplasty and stenting of lat-
se death for patients undergoing on-pump (On) and
umulative unadjusted survival from cardiac death for
and patients with CRV and IRV. Numbers in paren-
.-cau
B, C
CABG
tageseral and inferior wall targets.
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CDStudy Limitations
Our study is subject to all the limitations inherent in a
retrospective review. There was significant selection bias in
choosing which patients received CRV and IRV and OPCAB
versus on-pump CABG techniques. To minimize these bi-
ases, we chose to analyze both all-cause death and cardiac
death. Cardiac death as an outcome variable should be more
closely linked to completeness of revascularization than
all-cause death. Multivariable logistic and Cox regression
analyses were then used to adjust for confounding risk
factors. However, these methods cannot entirely eliminate
biases in an observational study.
Other potential limitations include the relatively small
numbers of patients in the subgroup analysis of patients 80
years of age or older and in the OPCAB patients with CRV
and IRV, as well as the small number of cardiac deaths, of
which we had 68. Preoperative coronary angiogram reports
might not be as accurate as systematic interpretation by a
single group of experienced readers.
Conclusions
CRV remains desirable, even in the current era of arterial
grafting and OPCAB techniques. In fact, arterial grafting
appears to improve survival in patients undergoing CABG
independent of the completeness of revascularization. The
survival benefit of CRV seems greater in patients less than
80 years of age. IRV is more prevalent in OPCAB opera-
tions. However, similar results can be achieved in OPCAB
operations if patients are completely revascularized. Pa-
tients undergoing CABG should have CRV with arterial
grafts to maximize survival.
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Discussion
Dr Robbin G. Cohen (Los Angeles Calif). Tom, that was a nice
presentation and I would venture to say that you are preaching to
the choir. Still, the benefits of complete myocardial revasculariza-
tion have recently been challenged by both the interventional
cardiology community and cardiac surgeons who have found it
necessary to modify their coronary operation to decrease early
operative morbidity and mortality. I think that your article has the
potential to be important because it reminds us that despite im-
provements in an area like myocardial protection and increased
arterial graft use, IRV still results in decreased survival, and that is
basically your take-away message. Having said that, I am con-
cerned about a couple of things that I think cloud your study, and
the first is the fact that a significant number of patients who were
incompletely revascularized had off-pump CABG early in the
operative experience of the authors. The result is that we do not
know whether the IRV in the off-pump group was due to patient
characteristics, such as diffuse disease or inadequate targets, ver-
sus the possibility that they actually had a different type of oper-
ation than the on-pump cohort. Therefore my first question is as
follows: Which was it that led to the increased rate of incomplete
revascularization in the off-pump group, bad disease or a learning
curve with a new technical procedure?
Dr Kleisli. Taking into consideration that our study is a retro-
spective analysis, we are somewhat limited by the information
available to us in terms of the decision-making process at the time
of the operation. However, I can say that there was significant
surgeon bias in terms of selecting which patients received on-
pump versus off-pump CABG, as well as complete versus incom-
plete revascularization. As such, we could not really look at it in
terms of disease.
Dr Cohen. I was a little confused by your method, and the
definition of complete revascularization was when at least one
bypass graft was placed distal to a 50% or greater narrowing in
each diseased territory. Now this implies that a patient could have,
for example, tight stenoses in both an LAD and a large diagonal
artery that you could place a graft to one of those vessels, and in
your study you considered that to be completely revascularized.
Similarly, a single graft, such as an obtuse marginal territory that
had multiple large vessels with disease, would also be considered
complete revascularization in your study. My question is, isn’t it
possible that there were a large number of patients in your com-
pletely revascularized group that others might have considered
incompletely revascularized, and isn’t that what might make your
study look different from previous similar studies that actually do
not show a difference in fewer grafts in terms of them being
revascularized or not?
Dr Kleisli. In regard to our definition, it is a functional classi-
fication revascularization. Therefore for a patient to be considered
completely revascularized, there needed to be at least 1 graft
placed into each territory, for example, 1 graft to the LAD, 1 to the
circumflex, and 1 to the right coronary territory.
In regard to the completeness of revascularization, most pa-
tients who were completely revascularized received the appropri-
ate amount of grafts into their territories. For example, if a patient
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CDhad disease in the LAD and the circumflex and the right coronary
artery and they received 3 grafts, this would be considered appro-
priate for the number of lesions. However, there were also numer-
ous patients who received more grafts than the number of stenoses
that were present, leading them to receive 4 or 5 grafts, which
would make them completely revascularized.
Dr Cohen. I understand your answer, but I am not sure that I
agree with it, and I still think that your bias was toward calling
some patients completely revascularized who really were not. At
any rate, I think it is a nice article. It has the potential to be
important, and I appreciate the opportunity to discuss it.
Dr Wen Cheng (Los Angeles, Calif). I am one of the surgeons
on this study from Cedars-Sinai, and I wanted to tell Dr Cohen
how we arrived at the definition of complete revascularization.
Vander Salm and colleagues, reviewing the BARI study, looked at
3 or 4 different definitions of completeness of revascularization.
Also, multiple other articles, including the Emory study and the
Coronary Artery Surgery registry, decided to use a functional
classification in which completeness of revascularization was de-
termined by means of complete grafting of each ischemic territory.
The BARI study found that if you overgraft the patient (ie, you put
2 grafts into a lateral territory), those patients did worse. Therefore,
Thomas and I chose to use a functional classification rather than
traditional classification of grafting every single diseased vessel.
Regarding the learning curve, we started doing off-pump op-
erations back in 1995. In 1998, we were doing about 15% off-
pump operations; in 1999, 28%; and in 2000, about 20%. We
elected to focus our experience on the time period of 1998 through
2000 because we were doing off-pump operations in a fairly
standardized fashion. We did not have the apical suction stabilizer,
for example, but we were using techniques that we were comfort-
able with, and our learning curve was believed to be less. It does
not completely eliminate a learning curve, but I believe that it was
minimized. I think the strength of the study is the magnitude of the
differences. In many of the other studies, you are talking a 5% to
10% survival advantage. In fact, in the Emory study out to 11 years
that advantage disappeared. That was due to perhaps their exclu-
sive use of saphenous vein grafting. The magnitude of the advan-
tage here is large: 30% for all-cause death and 20% for cardiac
death. Therefore, I think the strength of the study—Thomas did an
excellent job with this study—is that the magnitude is quite large.
Thomas and I reviewed all the charts, and we are comfortable with
The Journal of Thoracicusing a functional definition for completeness of the revascular-
ization.
Dr Anthony Furnary (Portland, Ore). Nicely presented. I
have 2 questions. One, I did not see an analysis of how use of the
radial artery affected survival, and certainly in an analysis like this,
where radial artery use is different in the differing groups, one
would need to factor that in in a multivariable analysis. Was that
done? Did you do multivariable analysis of the things that actually
did affect survival?
Dr Kleisli. Yes, we did perform multivariable analysis. I have
some backup slides with this information to show, but we did not
specifically look at the radial artery as one of our variables.
Dr Furnary. Did you look at the radial artery as one of the
variables?
Dr Kleisli. As of this point, we have not.
Dr Furnary. I think that should be done. Maybe one of you
could answer this. What do you think the clinical implications of
this study are vis a vis extending our revascularization with wraps
to extremely small vessels, the use of transmyocardial laser revas-
cularization, the use of gene therapy?
Dr Kleisli. I think that complete revascularization is still an
important concept, regardless of the fact that there are other
treatment modalities available to help our patients, such as
TMR and all the other techniques you just mentioned. There-
fore, I think our take-home message is still important, regard-
less of the fact that there are other interventional methods to
help out the patient.
Dr Daniel Wong (Boston, Mass). This was a really nice study
and a very provocative topic. My question is along the same lines.
I was quite interested in your abstract that you mentioned that you
had done some logistic regression, and I was wondering whether
you could comment—this is just from your abstract—that you
found that incomplete revascularization was a predictor of death;
however, there were other things that predicted that. What happens
when you put those into the model? Did the effect of incomplete
revascularization go away then?
Dr Kleisli. That depended on our outcome variable. If we look
at cardiac death in regard to which variables influenced cardiac
death, we found that incomplete revascularization, age, and dia-
betes were important predictors. However, in regard to all-cause
death, incomplete revascularization ended up not being a predictor
for this outcome.
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Figure E2. A, Cumulative unadjusted survival from all-c
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right coronary artery.
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plete revascularization
Reason
IRV IRV On-pump IRV OPCAB
Total
no. % of 97 No. % of 52 No. % of 45
Small and/or severe
disease
33 34.0 24 46.2 9 20.0
Nondominant 14 14.4 5 9.6 9 20.0
Infarcted tissue 12 12.4 11 21.2 1 2.2
High risk 12 12.4 0 0.0 12 26.7
Collaterals 10 10.3 4 7.7 6 13.3
No conduit
available
9 9.3 4 7.7 5 11.1
No reason 7 7.2 4 7.7 3 6.7
Total 97 100 52 100 45 100
IRV, Incomplete revascularization; OPCAB, off-pump coronary artery
bypass.TABLE E1. Variables entered into multivariable analyses
Incremental risk
factor
Logistic regression Cox proportional hazard
Incomplete
revascularization
All-cause and cardiac
death
Age ✓ ✓
EF ✓ ✓
CHF ✓ ✓
DM ✓ ✓
Prior MI ✓ ✓
HTN ✓ ✓
Female sex ✓ ✓
COPD ✓ ✓
CVA ✓ ✓
PVD ✓ ✓
CVA, in-hospital ✓
LM ✓ ✓
No. of territories
diseased
✓ ✓
IRV ✓
Pump ✓ ✓
LITA ✓
RITA ✓
Radial artery ✓
Saphenous vein ✓
Cx territory ✓
RCA territory ✓
EF, Ejection fraction; CHF, congestive heart failure; DM, diabetes mellitus;
MI, myocardial infarction; HTN, hypertension; COPD, chronic obstructive
pulmonary disease; CVA, cerebrovascular accident; PVD, peripheral vas-
cular disease; LM, left main; IRV, incomplete revascularization; Pump,
procedure performed with cardiopulmonary bypass; LITA, left internal
thoracic artery; RITA, right internal thoracic artery; Cx, circumflex; RCA,June 2005
